Saved in:
Follow-on biologics hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.
| Corporate Author: | |
|---|---|
| Format: | Government Document Online Book |
| Language: | English |
| Published: |
Washington :
U.S. G.P.O.,
2008.
|
| Series: | S. hrg. ;
110-375 |
| Subjects: | |
| Online Access: | ONLINE VERSION ONLINE VERSION |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!